CN202236501U - 用于感染性伤口换药的蜂蜜敷料 - Google Patents
用于感染性伤口换药的蜂蜜敷料 Download PDFInfo
- Publication number
- CN202236501U CN202236501U CN 201120360526 CN201120360526U CN202236501U CN 202236501 U CN202236501 U CN 202236501U CN 201120360526 CN201120360526 CN 201120360526 CN 201120360526 U CN201120360526 U CN 201120360526U CN 202236501 U CN202236501 U CN 202236501U
- Authority
- CN
- China
- Prior art keywords
- wound
- honey
- dressing
- layer
- utility
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000012907 honey Nutrition 0.000 title claims abstract description 29
- 239000003814 drug Substances 0.000 title description 3
- 230000001524 infective effect Effects 0.000 title 1
- 206010052428 Wound Diseases 0.000 abstract description 28
- 208000027418 Wounds and injury Diseases 0.000 abstract description 28
- 241000894006 Bacteria Species 0.000 abstract description 7
- 208000015181 infectious disease Diseases 0.000 abstract description 7
- 238000011282 treatment Methods 0.000 abstract description 5
- 230000002924 anti-infective effect Effects 0.000 abstract description 4
- 206010059866 Drug resistance Diseases 0.000 abstract description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 3
- 150000001413 amino acids Chemical class 0.000 abstract description 3
- 230000002828 effect on organs or tissue Effects 0.000 abstract description 3
- 239000008103 glucose Substances 0.000 abstract description 3
- 230000035876 healing Effects 0.000 abstract description 3
- 230000002458 infectious effect Effects 0.000 abstract description 3
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000012010 growth Effects 0.000 abstract description 2
- 230000008439 repair process Effects 0.000 abstract description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 229940088710 antibiotic agent Drugs 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 206010048038 Wound infection Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
一种用于感染性伤口换药的蜂蜜敷料，包括固定层、基底层，所述的基底层上设有蜂蜜层。本实用新型提供的一种用于感染性伤口换药的蜂蜜敷料，对组织无毒副作用，可以有效的抑制或杀灭伤口细菌，避免出现耐药性，还提供组织细胞赖以生存的葡萄糖和氨基酸等营养物质，促进伤口组织修复生长。本实用新型可以提高伤口的治愈率及病人的满意度；同时其价格低廉、易于得到，操作方便，符合中低工薪阶层使用，同时可减轻换药工作量；临床有较广阔的抗感染治疗应用潜能和开发价值，值得临床推广应用。
Description
技术领域
本实用新型涉及一种用于外伤伤口的敷料，特别是一种用于感染性伤口换药的蜂蜜敷料。
背景技术
近年来，随着抗生素的广泛应用与滥用，造成伤口菌群失调，致使伤口感染难以控制；特别是近来“超级细菌”在各个国家相继发现，耐药细菌对人们健康构成了严重的威胁，已成为全球性关注的问题。
感染性难愈伤口的传统治疗方法为：传统采用创面清创后常规换药或局部使用抗生素换药，或待创面肉芽新鲜后行植皮术。缺点：临床疗效一直不佳，存在伤口愈合慢、换药时间长、换药工作量大；伤口局部血液供应差，全身使用抗生素难以在伤口局部达到有效浓度，或局部使用抗生素会加速细菌变异产生耐药性，导致伤口感染难以控制或继发其他感染等问题；也加重药物对患者的不良反应及经济负担；近些年来，各种新的治疗手段如新型抗感染敷料、皮肤替代物、生长因子、创面负压治疗技术等应用，因抗感染敷料对一些顽固感染效果差甚至无效，其价格贵，不易得到；同时一些新技术操作复杂、不方便应用等多种因素，既浪费了医疗资源，也增加患者的经济负担。
发明内容
本实用新型所要解决的技术问题是提供一种用于感染性伤口换药的蜂蜜敷料，可以抑制或杀灭伤口细菌，促进伤口组织修复生长。
为解决上述技术问题，本实用新型所采用的技术方案是：一种用于感染性伤口换药的蜂蜜敷料，包括固定层、基底层，所述的基底层上设有蜂蜜层。
本实用新型提供的一种用于感染性伤口换药的蜂蜜敷料，对组织无毒副作用，可以有效的抑制或杀灭伤口细菌，避免出现耐药性，还提供组织细胞赖以生存的葡萄糖和氨基酸等营养物质，促进伤口组织修复生长。本实用新型可以提高伤口的治愈率及病人的满意度；同时其价格低廉、易于得到，操作方便，符合中低工薪阶层使用，同时可减轻换药工作量；临床有较广阔的抗感染治疗应用潜能和开发价值，值得临床推广应用。
附图说明
下面结合附图和实施例对本实用新型作进一步说明：
图1为本实用新型的整体结构示意图。
具体实施方式
如图1中，一种用于感染性伤口换药的蜂蜜敷料，包括固定层1、基底层2，所述的基底层2上设有蜂蜜层3。所述的固定层1为纱布绷带，带粘胶的纱布等材料，基底层2为无菌纱条。
使用时将新鲜蜂蜜杀菌后，倒入无菌盒内完全浸透无菌纱条制成蜂蜜敷料，室温、置阴凉处备用。使用方法：碘伏消毒伤口及周围皮肤，然后用生理盐水冲洗（以后换药时只需用生理盐水），根据伤口大小裁剪合适的蜂蜜敷料，紧贴伤口覆盖，外用无菌干纱布妥善固定。1次/天，感染控制后，1次/2-3天，直至愈合。
蜂蜜的作用机理及优点：
蜂蜜中的过氧化氢作用∶过氧化氢是蜂蜜的主要物质，已被确认为是细菌的“抑制剂”，且蜂蜜稀释所产生的过氧化氢的有害作用被降低，不会损伤人皮肤中的成纤维细胞，因而对伤口愈合无副作用。
蜂蜜的高渗透性抗菌作用：蜂蜜的抗菌特性是由其高糖成份的渗透性作用所致，且吸收伤口中脓液而起“清创作用”；直接作用于伤口时，在表面形成一层黏性屏障，既避免体液流失，又预防细菌入侵。 蜂蜜的酸性抑菌作用: 研究发现，天然蜂蜜是酸性的PH3.2-4.5，而引起伤口感染的大多数病原菌生长繁殖的适宜PH为7.0-7.5，因此，低浓度蜂蜜有抑菌作用，高浓度蜂蜜有杀菌作用。
蜂蜜刺激淋巴细胞和吞噬细胞活性增强，激活人体对感染的免疫反应；蜂蜜中的抗氧化成分有助于自由基清除，可有效减轻炎症反应。蜂蜜另一个参与组织修复的生长因子是胰岛素；蜂蜜不像其它的典型抗生素，对组织无毒副作用，，还提供组织细胞赖以生存的葡萄糖和氨基酸等营养物质。
Claims (1)
1.一种用于感染性伤口换药的蜂蜜敷料，包括固定层（1）、基底层（2），其特征在于：所述的基底层（2）上设有蜂蜜层（3）。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201120360526 CN202236501U (zh) | 2011-09-25 | 2011-09-25 | 用于感染性伤口换药的蜂蜜敷料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201120360526 CN202236501U (zh) | 2011-09-25 | 2011-09-25 | 用于感染性伤口换药的蜂蜜敷料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN202236501U true CN202236501U (zh) | 2012-05-30 |
Family
ID=46097815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201120360526 Expired - Fee Related CN202236501U (zh) | 2011-09-25 | 2011-09-25 | 用于感染性伤口换药的蜂蜜敷料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN202236501U (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015183228A1 (en) | 2014-05-27 | 2015-12-03 | Duymuş Ethem | Nano fiber cover for wounds and ambustions with an additive containing natural antiseptic |
| CN105169464A (zh) * | 2015-09-24 | 2015-12-23 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种天然蜂蜜伤口敷料及其制备方法与应用 |
| CN105769925A (zh) * | 2016-05-01 | 2016-07-20 | 长葛市怡盛蜂业有限公司 | 一种蜂蜜蜂胶理疗贴 |
-
2011
- 2011-09-25 CN CN 201120360526 patent/CN202236501U/zh not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015183228A1 (en) | 2014-05-27 | 2015-12-03 | Duymuş Ethem | Nano fiber cover for wounds and ambustions with an additive containing natural antiseptic |
| CN105169464A (zh) * | 2015-09-24 | 2015-12-23 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种天然蜂蜜伤口敷料及其制备方法与应用 |
| CN105169464B (zh) * | 2015-09-24 | 2018-05-15 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种天然蜂蜜伤口敷料及其制备方法与应用 |
| CN105769925A (zh) * | 2016-05-01 | 2016-07-20 | 长葛市怡盛蜂业有限公司 | 一种蜂蜜蜂胶理疗贴 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Alves et al. | Update on the role of antiseptics in the management of chronic wounds with critical colonisation and/or biofilm | |
| Davidson | Current concepts in wound management and wound healing products | |
| Brinkert et al. | Negative pressure wound therapy with saline instillation: 131 patient case series | |
| Daeschlein | Antimicrobial and antiseptic strategies in wound management | |
| Moghazy et al. | The clinical and cost effectiveness of bee honey dressing in the treatment of diabetic foot ulcers | |
| CN103495199B (zh) | 一种治疗激光灼伤和烧烫伤的水凝胶伤口敷料及其制备方法 | |
| US9655840B2 (en) | Wound care products | |
| Li et al. | Complications of negative pressure wound therapy: a mini review | |
| Raad et al. | Vacuum‐assisted closure instill as a method of sterilizing massive venous stasis wounds prior to split thickness skin graft placement | |
| Wollina et al. | Medical leech therapy (Hirudotherapy). | |
| Tuncel et al. | Clinical evaluation of gauze‐based negative pressure wound therapy in challenging wounds | |
| Giri et al. | Does negative pressure wound therapy with saline instillation improve wound healing compared to conventional negative pressure wound therapy?-A randomized controlled trial in patients with extremity ulcers | |
| Dhamnaskar et al. | Prospective comparative observational study of safety and efficacy of topical ozone gas therapy in healing of diabetic foot ulcers versus only conventional wound management | |
| CN102133451B (zh) | 创面雾化给药暨间歇负压封闭引流装置 | |
| CN202236501U (zh) | 用于感染性伤口换药的蜂蜜敷料 | |
| Woodward | Silver dressings in wound healing: what is the evidence? | |
| Doughty | Dressings and more: guidelines for topical wound management | |
| Ovington | Battling bacteria in wound care | |
| CA2829731A1 (en) | Use of sterile intravenous or intracavernous glycerin in destruction of bacterial biofilm | |
| Sandoz | Negative pressure wound therapy: clinical utility | |
| Swaim et al. | Management of small animal distal limb injuries | |
| Chen et al. | Distribution characteristics of pathogens in different stages of pressure ulcers and the therapeutic effect of linear polarized polychromatic light combined with silver sulfadiazine cream | |
| Tatu | The use of a topical compound cream product with Chitosan, Silver Sulfadiazine Bentonite hidrogel and Lactic acid for the treatment of a patient with Rosacea and ulcerated Livedoid Vasculopathy | |
| Ji et al. | Sanguis draconis (Daemonorops draco): a case report of treating a chronic pressure ulcer with tunneling | |
| EDWARDS | Use of SILVERCEL® NONADHERENT on burn wounds: A case series. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120530 Termination date: 20120925 |